May 11, 2020 / 12:55 PM / 21 days ago

BRIEF-Galectin Therapeutics Reports Financial Results For The Quarter Ended March 31, 2020, And Provides Business Update

Galectin Therapeutics Inc:

* GALECTIN THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2020, AND PROVIDES BUSINESS UPDATE

* Q2 LOSS PER SHARE $0.06

* GALECTIN THERAPEUTICS - EXPECTS IT WILL REQUIRE MORE CASH TO FUND OPERATIONS AFTER SEPT 30, 2021, BELIEVES WILL BE ABLE TO OBTAIN FINANCING AS NEEDED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below